Photo of: Robert Timmerman

Dr. Robert D. Timmerman

View Title...

Robert's profile was created using:
Sort By:

1-10 of 33 online sources for Robert Timmerman

  • View Online Source
    www.cancerfacts.com/Home_News.asp?NewsId=2218&CB=14&Can - [Cached Version]
    Published on: 9/20/2007    Last Visited: 12/5/2007  

    Led by Dr. Robert Timmerman, vice chairman of radiation oncology at the University of Texas Southwestern, the researchers will test the effectiveness of stereotactic body radiation therapy (SBRT), a relatively new technique that delivers very high doses of focused radiation to precisely targeted tumors.Dr. Timmerman has successfully used the technique to treat patients with lung and liver cancers.

    "There are a number of good treatments for prostate cancer, but they all have some drawbacks , they're inconvenient; they're invasive; or they cause impotence, rectal injury or urinary incontinence," said Dr. Timmerman.
    ...
    "This new treatment mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia," Timmerman says."The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half."

    Dr. Timmerman has treated 11 prostate cancer patients at UT Southwestern using this new method with only minor side effects.So far, Timmermans says they are seeing that the PSA levels in patients undergoing this new therapy decline more rapidly than one would expect with conventional treatment.

    As part of the study, he is trying to establish the treatment's proper dose and protocol.He also is establishing study sites at the University of Minnesota, University of Colorado and at a rural practice in South Dakota.

    Dr. Timmerman said the SBRT treatment might be ideal for people who live far away from an academic medical center or who can't stay away from their jobs for extended periods of time to receive treatment or recover.

    "We're targeting this population because they clearly need a better treatment," Timmerman says.

  • View Online Source
    www.rt-image.com/Examine__PACS_Outside_the_Viewbox_A_ho - [Cached Version]
    Published on: 7/8/2008    Last Visited: 7/8/2008  

    Robert Timmerman, MD, vice chairman of radiation oncology at Dallas-based UT Southwestern Medical Center is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.

    The SBRT technique is a relatively new procedure used for treating localized tumors by delivering high doses of focused radiation.Timmerman has successfully used the technique to treat patients with lung and liver cancers.

    "There are a number of good treatments for prostate cancer, but they all have some drawbacks , they're inconvenient; they're invasive; or they cause impotence, rectal injury or urinary incontinence," Timmerman says.

    This new treatment is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia.

    "The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half," Timmerman says.

    Timmerman has treated 11 patients at UT Southwestern using this new method, with only minor side effects.Healthcare experts predict that about 218,000 new cases of prostate cancer will be diagnosed in the United States this year, and more than 27,000 men will die from the disease.

    Timmerman says the SBRT treatment might be ideal for people who live far away from an academic medical center or those who can't stay away from their jobs for extended periods of time to receive treatment or recover.

    "We're targeting this population because they clearly need a better treatment," Timmerman says.

  • View Online Source
    www.clevelandclinicmeded.com/ASPCL01B/SBRT07/index.asp - [Cached Version]
    Published on: 2/23/2007    Last Visited: 3/18/2007  

    Robert Timmerman, MD Professor and Vice Chair, RadiationOncologyUT Southwestern Medical Center
    ...
    Robert Timmerman

  • View Online Source
    www.thecbce.com/upcomingActivities_detail.aspx?act_id=1 - [Cached Version]
    Published on: 4/5/2007    Last Visited: 4/5/2007  

    Robert Timmerman, MDProfessorThe University of Texas Southwestern Medical Center
    ...
    Robert Timmerman
    ...
    Robert Timmerman

  • View Online Source
    www.prairielakes.com/news/index.php?newsid=393 - [Cached Version]
    Published on: 3/17/2008    Last Visited: 6/16/2008  

    Watertown native Dr. Robert Timmerman is leading the national study.He is Vice-Chairman of Radiation Oncology at UT Southwestern Medical Center in Dallas, Texas.In addition to Prairie Lakes Cancer Center and UT Southwestern, Dr. Timmerman has established study sites at the University of Minnesota and the University of Colorado. Prairie Lakes Cancer Center was chosen in part because of its rural setting.Dr. Timmerman said the new treatment technique addresses challenges faced by people living in rural or remote areas."If a farmer is diagnosed with prostate cancer during harvest season, he can ill afford to be absent, debilitated or generally frail or his family's very livelihood is threatened," he said."Our study is trying to work with people like farmers who have unique issues generally ignored in clinical studies."

    When Greening first heard that his treatments could potentially be reduced, he was very anxious to learn more about the study.
    ...
    Including all trial sites, Dr. Timmerman said 20 patients have completed the treatment phase of the prostate study since September 2006.
    ...
    "SBRT success is already established in cancers like brain, spine, lung, and liver," Dr. Timmerman said.

  • View Online Source
    www.dddmag.com/ShowPR.aspx?PUBCODE=016&ACCT=1600000100& - [Cached Version]
    Published on: 9/24/2007    Last Visited: 9/24/2007  

    Dr. Robert Timmerman, vice chairman of radiation oncology, UT Southwestern Medical Center, is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.The SBRT technique is a relatively new procedure used for treating localized tumors by delivering very high doses of focused radiation.Dr. Timmerman has successfully used the technique to treat patients with lung and liver cancers.

    "This new treatment mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia," Dr. Timmerman said."The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half."

    Dr. Timmerman has treated 11 patients at UT Southwestern using this new method with only minor side effects.As part of the study, he is trying to establish the treatment's proper dose protocol.He also is establishing study sites at the University of Minnesota, University of Colorado, and at a rural practice in South Dakota.

  • View Online Source
    indiana.localoncologists.com/showListing/id/5949453/nam - [Cached Version]
    Published on: 7/20/2008    Last Visited: 7/20/2008  

    Robert Dale TimmermanLocal Oncologists Listing - Robert Dale Timmerman
    ...
    Home > Indiana > Indianapolis > Robert Dale Timmerman > >
    ...
    Robert Dale Timmerman

    Address Information

    Robert Dale Timmerman

    Indianapolis, IN 46278

  • View Online Source
    www.eurekalert.org/pub_releases/2007-09/usmc-rtt091707. - [Cached Version]
    Published on: 9/20/2007    Last Visited: 9/20/2007  

    Dr. Robert Timmerman and radiation therapist, Sheree Kincaid, get patient Breihan Bridgewater ready for treatment.
    ...
    Dr. Timmerman is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.

    The SBRT technique is a relatively new procedure used for treating localized tumors by delivering very high doses of focused radiation.Dr. Timmerman has successfully used the technique to treat patients with lung and liver cancers.

    "There are a number of good treatments for prostate cancer, but they all have some drawbacks - they're inconvenient; they're invasive; or they cause impotence, rectal injury or urinary incontinence," said Dr. Timmerman.
    ...
    "This new treatment mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia," Dr. Timmerman said."The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half."

    Dr. Timmerman has treated 11 patients at UT Southwestern using this new method with only minor side effects.As part of the study, he is trying to establish the treatment's proper dose protocol.He also is establishing study sites at the University of Minnesota, University of Colorado and at a rural practice in South Dakota.

    Health-care experts predict that about 218,000 new cases of prostate cancer will be diagnosed in the U.S. this year, and more than 27,000 men will die from the disease.

    Dr. Timmerman said the SBRT treatment might be ideal for people who live far away from an academic medical center or who can't stay away from their jobs for extended periods of time to receive treatment or recover.

    "We're targeting this population because they clearly need a better treatment," Dr. Timmerman said.
    ...
    "Actually, we are seeing that the PSA levels in patients undergoing this new therapy are declining more rapidly than one would expect with conventional treatment," Dr. Timmerman said.
    ...
    Dr. Robert Timmerman - http://www.utsouthwestern.edu/patientcare/doctor/findphysician/profile/0,0,
    69821 Dr Robert Timmerman MD &fpSB=lName&fpNR=50&fpJump=0&fpType=&firstName=&lastName=Timmerman&gender=A
    ny&language=Any&webServiceSlt=Any&webProgramSlt=&clnInterestSlt=Any&searchT
    ype=physName&specialty=Any&index=1,00.html

  • View Online Source
    www.sciencedaily.com/releases/2007/09/070920091217.htm - [Cached Version]
    Published on: 9/24/2007    Last Visited: 9/25/2007  

    Dr. Robert Timmerman and radiation therapist, Sheree Kincaid, get patient Breihan Bridgewater ready for treatment. (Credit: Image courtesy of UT Southwestern Medical Center)
    ...
    Dr. Timmerman is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.

    The SBRT technique is a relatively new procedure used for treating localized tumors by delivering very high doses of focused radiation.Dr. Timmerman has successfully used the technique to treat patients with lung and liver cancers.

    "There are a number of good treatments for prostate cancer, but they all have some drawbacks -- they're inconvenient; they're invasive; or they cause impotence, rectal injury or urinary incontinence," said Dr. Timmerman.
    ...
    "This new treatment mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia," Dr. Timmerman said."The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half."

    Dr. Timmerman has treated 11 patients at UT Southwestern using this new method with only minor side effects.As part of the study, he is trying to establish the treatment's proper dose protocol.He also is establishing study sites at the University of Minnesota, University of Colorado and at a rural practice in South Dakota.

    Health-care experts predict that about 218,000 new cases of prostate cancer will be diagnosed in the U.S. this year, and more than 27,000 men will die from the disease.

    Dr. Timmerman said the SBRT treatment might be ideal for people who live far away from an academic medical center or who can't stay away from their jobs for extended periods of time to receive treatment or recover.

    "We're targeting this population because they clearly need a better treatment," Dr. Timmerman said.
    ...
    "Actually, we are seeing that the PSA levels in patients undergoing this new therapy are declining more rapidly than one would expect with conventional treatment," Dr. Timmerman said.

  • View Online Source
    www.astro.org/Meetings/ConferencesAndSymposia/IMRTPract - [Cached Version]
    Published on: 6/26/2007    Last Visited: 8/14/2007  

    Robert D. Timmerman, M.D.University of Texas
    ...
    Robert D. Timmerman, M.D.University of Texas

Page:  1 2 3 4 Next

Wrong Person?

Try these instead
Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM12